EL7.AI
Mergers & AcquisitionsMediumUpdated•Originally published 5 October 2026•Updated 5 October 2026•
1 min read

GE HealthCare to Acquire Radiopharmaceutical Firm for $945 Million

Key Facts

1GE HealthCare is expected to announce a $945 million cash acquisition of a manufacturer of radioactive substances used in medical imaging.

GE HealthCare is expected to announce a $945 million cash acquisition of a manufacturer of radioactive substances used in medical imaging. The Wall Street Journal reported that the move is part of the company's efforts to strengthen its footprint in the radiopharmaceutical sector.

The acquisition aims to bolster operations in the radiopharmaceuticals segment, which is currently GE HealthCare's fastest-growing business unit. This development comes as global markets focus on advanced healthcare technologies and the company continues to expand its medical diagnostic solutions.

Latest Updates · 1

  1. Notable·

    Update: GE HealthCare has identified Sofie Biosciences as the target of the acquisition. The identification confirms the details of the $945 million cash deal intended to expand the company's radiopharmaceutical capabilities.